Blood Cancer Journal (May 2023)
Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
- Ioannis Mitroulis,
- Vasileios Papadopoulos,
- Eleftheria Lamprianidou,
- Peter Mirtschink,
- Konstantinos Liapis,
- Kalliopi Zafeiropoulou,
- Alexandra Kourakli,
- Theodoros Moysiadis,
- Menelaos Papoutselis,
- George Vrachiolias,
- Argiris Symeonidis,
- Ioannis Kotsianidis
Affiliations
- Ioannis Mitroulis
- Department of Hematology, Democritus University of Thrace Medical School
- Vasileios Papadopoulos
- Department of Hematology, Democritus University of Thrace Medical School
- Eleftheria Lamprianidou
- Department of Hematology, Democritus University of Thrace Medical School
- Peter Mirtschink
- Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden
- Konstantinos Liapis
- Department of Hematology, Democritus University of Thrace Medical School
- Kalliopi Zafeiropoulou
- Hematology Division, Department of Internal Medicine, University of Patras Medical School
- Alexandra Kourakli
- Hematology Division, Department of Internal Medicine, University of Patras Medical School
- Theodoros Moysiadis
- Department of Computer Science, School of Sciences and Engineering, University of Nicosia
- Menelaos Papoutselis
- Department of Hematology, Democritus University of Thrace Medical School
- George Vrachiolias
- Department of Hematology, Democritus University of Thrace Medical School
- Argiris Symeonidis
- Hematology Division, Department of Internal Medicine, University of Patras Medical School
- Ioannis Kotsianidis
- Department of Hematology, Democritus University of Thrace Medical School
- DOI
- https://doi.org/10.1038/s41408-023-00844-4
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 5
Abstract
No abstracts available.
